Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments
暂无分享,去创建一个
M. Nakagawa | H. Ishiura | J. Mitsui | H. Takashima | Y. Okamoto | A. Yoshimura | I. Yabe | Mamoru Yamamoto | Y. Sanpei | M. Matsushima | Makoto Takahashi | A. Hashiguchi | Y. Higuchi | M. Ando | N. Matsuda | S. Tsuji | Taichi Nomura | T. Taniguchi | M. Yoshino | E. Dohi
[1] R. Lewis,et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision , 2021, European journal of neurology.
[2] R. Lewis,et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision , 2021, Journal of the peripheral nervous system : JPNS.
[3] T. Murohara,et al. Multidisciplinary Approaches for Transthyretin Amyloidosis , 2021, Cardiology and Therapy.
[4] S. Tsuji,et al. Genetic spectrum of Charcot–Marie–Tooth disease associated with myelin protein zero gene variants in Japan , 2020, Clinical genetics.
[5] W. Wiszniewski,et al. Screening for genetic mutations in patients with neuropathy without definite etiology is useful , 2020, Journal of Neurology.
[6] Paco Derouault,et al. CovCopCan: An efficient tool to detect Copy Number Variation from amplicon sequencing data in inherited diseases and cancer , 2020, PLoS Comput. Biol..
[7] P. Hawkins,et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy , 2020, Journal of Neurology.
[8] Aslıhan Uzunkulaoğlu,et al. Terminal Latency Index, Residual Latency, and Median-Ulnar F-Wave Latency Difference in Carpal Tunnel Syndrome , 2019, Annals of Indian Academy of Neurology.
[9] A. Gracia Gutiérrez,et al. Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data , 2019, European Journal of Human Genetics.
[10] T. Yokochi,et al. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report , 2018, Journal of Medical Case Reports.
[11] L. Santoro,et al. Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise” , 2018, Orphanet Journal of Rare Diseases.
[12] M. Nakagawa,et al. Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[13] J. Sung,et al. Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis , 2018, Journal of clinical neurology.
[14] S. Solomon,et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis , 2018, The New England journal of medicine.
[15] D. Herrmann,et al. Carpal tunnel syndrome in inherited neuropathies: A retrospective survey , 2018, Muscle & nerve.
[16] L. Amass,et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy , 2018, Muscle & nerve.
[17] Y. Ando,et al. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm , 2018, Orphanet Journal of Rare Diseases.
[18] H. Feigenbaum,et al. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[19] S. Tsuji,et al. Clinical and genetic diversities of Charcot‐Marie‐Tooth disease with MFN2 mutations in a large case study , 2017, Journal of the peripheral nervous system : JPNS.
[20] L. Amass,et al. Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[21] B. Vahdatpour,et al. Comparative study of shock wave therapy and Laser therapy effect in elimination of symptoms among patients with myofascial pain syndrome in upper trapezius , 2016, Advanced biomedical research.
[22] B. Vahdatpour,et al. The role of median nerve terminal latency index in the diagnosis of carpal tunnel syndrome in comparison with other electrodiagnostic parameters , 2016, Advanced biomedical research.
[23] S. Tsuji,et al. Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2 , 2016, Annals of neurology.
[24] B. Hazenberg,et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy , 2016, Current opinion in neurology.
[25] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[26] Hee-Jin Kim,et al. Asp58Ala is the Predominant Mutation of the TTR Gene in Korean Patients with Hereditary Transthyretin‐Related Amyloidosis , 2015, Annals of human genetics.
[27] Tomonori Nakamura,et al. Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs , 2014, Journal of the peripheral nervous system : JPNS.
[28] H. Takashima,et al. A family with distal hereditary motor neuropathy and a K141Q mutation of small heat shock protein HSPB1. , 2014, Internal medicine.
[29] Yukio Ando,et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians , 2013, Orphanet Journal of Rare Diseases.
[30] G. Sobue,et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[31] J. Vallat,et al. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy , 2012, Muscle & nerve.
[32] C. Briani,et al. Variable presentations of TTR‐related familial amyloid polyneuropathy in seventeen patients , 2011, Journal of the peripheral nervous system : JPNS.
[33] G. Sobue,et al. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis , 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[34] K. Ono,et al. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus , 2008, Journal of the Neurological Sciences.
[35] B. Kim,et al. Subclinical diabetic neuropathy with normal conventional electrophysiological study , 2007, Journal of Neurology.
[36] Masaaki Nakamura,et al. Transthyretin-related familial amyloidotic polyneuropathy. , 2005, Archives of neurology.
[37] G. Sobue,et al. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[38] J. Koyama,et al. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[39] G. Sobue,et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. , 2003, Brain : a journal of neurology.
[40] G. Sobue,et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. , 2002, Archives of neurology.
[41] G. Sobue,et al. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. , 2002, Neurology.
[42] S. Yamaguchi,et al. Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[43] S. Ikeda,et al. Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[44] D. Simovic,et al. The median nerve terminal latency index in carpal tunnel syndrome: A clinical case selection study , 1999, Muscle & nerve.
[45] Yoshiya Tanaka,et al. Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction , 1994, The Lancet.
[46] Y. Yamamura,et al. Studies on familial amyloid polyneuropathy in Ogawa Village, Japan. , 1980, European neurology.
[47] P K Thomas,et al. The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.
[48] M. Ohta,et al. Polyneuritic amyloidosis in a Japanese family. , 1968, Archives of neurology.
[49] C ANDRADE,et al. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. , 1952, Brain : a journal of neurology.